1. Describe patterns in the clinical features and disease trajectories of patients in the DodoNA migraine cohort.
2. Describe how a genetic risk score is calculated and its potential clinical utility.
3. Discuss the interpretation of a specific migraine genetic risk score in the context of clinical features seen in the DodoNA migraine cohort.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation